Pathophysiology of the blood-brain barrier
Author(s)
Bibliographic Information
Pathophysiology of the blood-brain barrier
(Fernström Foundation series, v. 14)
Elsevier , Sole distributors for the USA and Canada, Elsevier Science Pub. Co., 1990
Available at 5 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Description and Table of Contents
Description
The blood-brain barrier, a concept including all morphological and functional mechanisms that restricts or facilitates the passage of substances from blood to brain, enables the brain environment to be regulated relatively independently from concentration and fluctuations in plasma constituents. The various aspects on the blood-brain barrier have been extensively discussed in a number of recent symposia and our knowledge on the blood-brain barrier physiology has advanced impressively during the last decade. However, as to the pathophysiology and the long-term consequences of a transient or permanent barrier damage, little is known - a fact attributable to the limited amount of interest shown in this area of research until recently. The idea to arrange a Fernstrom symposium on the consequences of barrier damage emerged in 1987, when findings in Barbro Johansson's Laboratory of Experimental Neurology indicated that opening of the blood-brain barrier in various experimental models could lead to permanent neuronal injury.
Table of Contents
Content Headings: List of Participants. Preface. The Erik K. Fernstrom Foundation. Acknowledgements. Section I. Current Concepts of the Blood-Brain Barrier (papers 1-8). Section II. Pathophysiology of Barrier Mechanisms (papers 9-16). Section III. Therapeutic Role of Barrier Modifications (papers 17-22). Section IV. Blood-Brain Barrier in Neurotoxicology (papers 23-27). Section V. The Blood-Brain Barrier in the Pathophysiology of Cerebrovascular Lesions (papers 28-34). Section VI . Afferent and Efferent Pathways from the Brain to the Immune System (papers 35-41). Section VII . Antigen Presentation in the Central Nervous System (papers 42-44). Section VIII . Immunocytotherapy in the Brain (papers 45-47). Section IX . Transplantation in the Central Nervous System (papers 48-53). Full contents list available on request from the Publisher. Imprint Amsterdam
by "Nielsen BookData"